Post-Authorization Activity Table (PAAT) for Bexsero

Health Canada Post-Authorization Activity Table 2019-01-17, Bexsero, Recombinant Neisseria meningitidis serogroup B Neisseria Heparin Binding Antigen (NHBA) fusion protein, 50 µg/0.5 mL; Recombinant Neisseria meningitidis serogroup B Neisserial Adhesin A fusion protein (NadA), 50 µg/0.5 mL; Recombinant Neisseria meningitidis serogroup B factor H binding protein (fHBP) fusion protein, 50 µg/0.5 mL; Recombinant Neisseria meningitidis serogroup B Outer Membrane Vesicles, 25 µg/0.5 mL, suspension, intramuscular injection, GlaxoSmithKline Inc.

Related Posts